MANGALAM DRUGS & ORGANICS LIMITED Mangalam Drugs & Organics Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 3,701.95 million compared to INR 4,508.62 million a year ago. Revenue was INR 3,722.53 million compared to INR 4,510.68 million a year ago.
Net income was INR 12.7 million compared to INR 196.57 million a year ago. Basic earnings per share from continuing operations was INR 0.8 compared to INR 12.42 a year ago. Diluted earnings per share from continuing operations was INR 0.8 compared to INR 12.42 a year ago.
